Uncategorized

According to the Union Ministry of health and family welfare, India reports 45,209 new COVID-19 cases . The total number of deaths is 501 in 24 hours and the total number of deaths from the outbreak has total increased to 1,33,227.

The total COVID-19 cases are 90,95,807.

Indian council of medical research (ICMR) reports 10,75,326 sample tests have been done in last 24 hours.

Delhi reports maximum number of COVID-19 cases 5,879 and 11 deaths in last 24 hours.The total number of positive COVID-19 cases are 5,23,117.

In Ayurveda students who will do Postgraduate, they will now be trained and allowed to perform a few general surgeries in ENT, Opthalmology, and dental procedures. The Central Council of Indian Medicine amended the Indian Medicine Central Council (Post Graduate Ayurveda Education) Regulation,2016, to allow Postgraduate students to practice surgery.

According to the gazette notification “During the period of study, the PG scholar of Shalya and Shalakya shall be practically trained to acquaint with as well as to independently perform the following activities so that completion of his/her PG degree, he/she is able to perform the Shalya Tantra (General surgery) independently.”

Indian Medical Association has been opposing the Centre’s move to allow traditional systems of Ayurveda, Yoga, Naturopathy , Homeopathy and Unani to offer allopathy therapies and treatment.

IMA has demanded the withdrawal of the order “Surgical disciplines of Modern Medicine have developed over the last half a millennium. Today Modern Medicine is capable of sophisticated surgical procedures and has the wherewithal to train generations of doctors through institutions of excellence and an ever-evolving scientific base. Corrupting Modern Medicine by mixing with other systems and poaching the disciplines of Modern Medicine through back door means is certainly foul play of first order. National Medical Commission should assert itself. NMC is equally responsible to protect the purity of Modern Medicine. People of India deserve better ways to Health.”

According to the Ministry of health and family welfare India’s total COVID-19 cases in 24 hours. India has crossed more than 90 lakh cases since outbreak. India’s total cases increased to 90,50,598 and total deaths are 564.Total number of deaths reported are 1,32,726.

Total number of tests in 24 hours – ICMR

The total number of samples tested up to 20 November is 13,06,57,808 including 10,66,022 samples tested in last 24 hours.

In Delhi Indian Council of Medical Research (ICMR) has increased the capacity of RT-PCR tests per day from 27,000 to 37,200.

Bharat BioTech has started phase-3 clinical trials. Haryana Health Minister Anil Vij has become the first volunteer for Bharat Biotech’s Covid-19 vaccine.

#WATCH Haryana Health Minister Anil Vij being administered a trial dose of #Covaxin, at a hospital in Ambala.

He had offered to be the first volunteer for the third phase trial of Covaxin, which started in the state today. pic.twitter.com/xKuXWLeFAB

— ANI (@ANI) November 20, 2020

Earlier Anil Vij said “Trial for third phase of Covaxin a coronavirus vaccine product of Bhart Biotech to start in Haryana on 20th November. I have offered myself as first volunteer to get vaccinated.”

In Phase – 3 drug trial Bharat Biotech will involve 26,000 volunteers from country.

The volunteers who wish to participate in the trial must be more than 18 years of age.

Pfizer has announced that its vaccine is 95% effective on the basis of Phase -3 trial .On Friday Pfizer has said its asking US regulators to allow emergency use of its COVID-19 vaccine.They have announced to submit a request to the U.S. Food and Drug Administration (FDA) for Emergency Use Autorization which will potentially enable the use of the vaccine in high-risk populations in the U.S by the middle to end of December 2020, Statement released by Pfizer

“Our work to deliver a safe and effective vaccine has never been more urgent, as we continue to see an alarming rise in the number of cases of COVID-19 globally. Filing in the U.S. represents a critical milestone in our journey to deliver a COVID-19 vaccine to the world and we now have a more complete picture of both the efficacy and safety profile of our vaccine, giving us confidence in its potential,” said Dr.Albert Borla, Pfizer , chairman and Ceo

Union Minister for Health and Family welfare has announced the decision of a Government to introduce new category called ‘Ward of COVID Warriors’. Five Central Pool MBBS seats have been reserved for ‘Wards of COVIDWarriors’ for the academic year 2020-21

“Proud to announce a new category for selection of candidates from ‘Wards of COVIDWarriors’ under Central Pool of MBBS/BDS seats to honour of the sacrifice of numerous ‘Covd Warriors’ who laid down their lives while serving society,” Tweeted Dr. Harsh Vardhan , Union Health Minister

It will honour the solemn sacrifice of all COVID warriors who served selflessly,” he added

The Union Health Minister Dr.Harsh Vardhan has said that India to get 400-500 million vaccines by July 2021. The Union Health Minister has given this statement during the virtual program organised by FICCI FLO. During a program, the National Treasurer Mrs. Lalita Nijhawan ,FICCI FLO in a frequently questioning session asked the Union health minister about the method of distribution of vaccinations across the country.

“First of all the priority has been chosen on the basis of medical grounds. Because we are a country of 135 crore people. For such large numbers of people, nobody can arrange large quantities of doses of vaccines in a single go. By July to August 2021, we will have 400-500 million dosages available. Now it is under clinical trials in many companies”.said Dr. Harsh Vardhan , Union health minister

The fastest and cheapest COVID-19 testing kit that will give results in less than 40 minutes launched today in collaboration with Apollo hospitals group and TataMD.Apollo Hospitals Group to begin with a roll-out of 10,000 tests in NCR from December 1st week

The kit will be marketed as “TataMD’s CHECK”, Tata Medical and Diagnostics Ltd (TataMD) had announced earlier.

The test likely to be less costly then RTPCR test and equally more then 90 per cent accurate.

“We have capacity of testing 1 million testing kit, but we can scale up quantity of kits according to the demand.” Said Girish Krishnamurthy, CEO & MD , Tata Medical and Diagnostics

“This kit will not be available on pharmacies it will be available only in well-equipped labs, special training will be provided to use it.” He added

.

According to the medical bulletin given by the Government of Delhi based on the cases reported in the last 24 hours i.e 7,486 new positive cases and 131 deaths. The total number of COVID-19 cases in Delhi crosses 5 lakh i.e 5,03,084 that includes 42,458 active cases and 7,943 deaths from the time of the outbreak.

The highest single day spike was reported 8,593 on November 11.